2635 MAJA trial: maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). Preliminary analysis of a randomized placebo controlled phase II trial. SOGUG 2011-02. EudraCT 2011-001271-39

Autor:	U. Anido Herranz, N. Lainez Milagro, M.A. Gonzalez Del Alba Baamonde, M.A. Climent Duran, M.D.M. Llorente Ostiategui, E. Gallardo Diaz, B. Perez Valderrama, S. Hernando Polo, M. Domenech Santasusana, J.A. Arranz Arija, J.C. Villa Guzman, A. Font Pous, X. Garcia del Muro Solans, J. Bellmunt Molins, B. Mellado Gonzalez, J. Puente Vázquez, J.L. Perez Gracia, J.A. Virizuela Echaburu, D. Castellano Gauna, J. Garcia Donas Jiménez
Rok vydání:	2015
Předmět:	Oncology Cisplatin Cancer Research medicine.medical_specialty Chemotherapy Vinflunine business.industry medicine.medical_treatment Placebo Preliminary analysis chemistry.chemical_compound chemistry Internal medicine medicine In patient business Urothelial carcinoma medicine.drug
Zdroj:	European Journal of Cancer. 51:S524-S525
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(16)31452-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::092ae44e80df389340a945cd3738523a https://doi.org/10.1016/s0959-8049(16)31452-6 Zobrazit plný text záznamu Full Text from ScienceDirect